DNA CON-S env
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
HIV Infections
Phase 1
Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults
CompletedNCT02296541
Start: 2014-12-31End: 2020-07-06Updated: 2023-04-24
Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected Adults
WithdrawnNCT03505060
Start: 2019-01-01End: 2019-11-11Updated: 2021-10-15